<DOC>
	<DOCNO>NCT00538486</DOCNO>
	<brief_summary>The epidemic obesity associate considerable rise incidence metabolic syndrome , type 2 diabetes mellitus , hypertension . Insulin resistance play important role pathogenesis obesity relate hypertension . These patient high risk suffer cardiovascular event . However , current guideline treatment hypertension provide specific recommendation pharmacotherapy obese hypertensive patient due lack prospective randomize intervention study non-diabetic obese hypertensive patient . Aside antihypertensive effect , angiotensin II receptor blocker ( ARB ) show improve insulin sensitivity . Furthermore , metformin commonly use treat obese type 2 diabetes mellitus . Metformin also low body weight increase insulin sensitivity . In prospective , double-blind , double-dummy , randomize , parallel-group study , evaluate effect ARB ( telmisartan candesartan ) amlodipine combination metformin weight gain , visceral fat , metabolic parameter obese hypertensive patient without diabetes mellitus compare obese hypertensive ARB amlodipine treatment alone . This study help develop future comprehensive treatment strategy guideline obesity related hypertension .</brief_summary>
	<brief_title>A Randomized , Double-Blind , Active Control Trial Comparing Effects Telmisartan , Candesartan Amlodipine , Alone Plus Metformin , Non-Diabetic , Obese Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Grade 1 2 hypertension : 140mmHg≤SBP &lt; 180mmHg , and/or 90mmHg≤DBP &lt; 110mmHg Waist circumference high 90cm men , 80cm woman Diabetes Grade 3 hypertension : SBP≥180mmHg , DBP≥110mmHg know allergy hypersensitivity trial drug Myocardial infarction cerebrovascular accident year precede trial Clinical Congestive Heart Failure History hepatitis cirrhosis History kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Abdominal obesity</keyword>
	<keyword>Treatment</keyword>
</DOC>